Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dambrova

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 25, 2014
Risks and benefits of carnitine supplementation in diabetesM Dambrova, E Liepinsh
Pharmacology & Toxicology|November 20, 1998
Characterization of guanoxabenz reducing activity in rat brainM Dambrova, S Uhlén, J E Wikberg
Biochemical Pharmacology|November 5, 1998
Conditions for biphasic competition curves in radioligand binding for ligands subjected to metabolic transformationJ E Wikberg, M Dambrova, S Uhlén, et al.
Biochemical and Biophysical Research Communications|September 7, 2000
Improved method for EPR detection of DEPMPO-superoxide radicals by liquid nitrogen freezingM Dambrova, L Baumane, I Kalvinsh, et al.
European Journal of Biochemistry|November 3, 1998
Identification of an N-hydroxyguanidine reducing activity of xanthine oxidaseM Dambrova, S Uhlén, C J Welch, et al.
Likars'Ka Sprava|June 24, 2004
[Biochemical mechanisms of mildronate action during ischemic stress]M Dambrova, D Daĭia, E Liepin'sh, et al.
Kardiologiia|December 4, 2014
[Carnitine as a marker of atherosclerosis and other risks of cardiovascular diseases]M Dambrova, M Makretskaia, R Vilshkersts, et al.
Molecular Neurobiology|April 30, 2017
The Differentiation of Skin Mesenchymal Stem Cells Towards a Schwann Cell Phenotype: Impact of Sigma-1 Receptor ActivationL Saulite, E Vavers, L Zvejniece, et al.
Archives of Biochemistry and Biophysics|April 25, 2000
N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radicalM Dambrova, L Baumane, A Kiuru, et al.
Biochemical Pharmacology|November 5, 1998
Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. I. Description of an enzymatic activity in spleen membranesS Uhlén, M Dambrova, G Tiger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 25, 2014
Risks and benefits of carnitine supplementation in diabetesM Dambrova, E Liepinsh
Pharmacology & Toxicology|November 20, 1998
Characterization of guanoxabenz reducing activity in rat brainM Dambrova, S Uhlén, J E Wikberg
Biochemical Pharmacology|November 5, 1998
Conditions for biphasic competition curves in radioligand binding for ligands subjected to metabolic transformationJ E Wikberg, M Dambrova, S Uhlén, et al.
Biochemical and Biophysical Research Communications|September 7, 2000
Improved method for EPR detection of DEPMPO-superoxide radicals by liquid nitrogen freezingM Dambrova, L Baumane, I Kalvinsh, et al.
European Journal of Biochemistry|November 3, 1998
Identification of an N-hydroxyguanidine reducing activity of xanthine oxidaseM Dambrova, S Uhlén, C J Welch, et al.
Likars'Ka Sprava|June 24, 2004
[Biochemical mechanisms of mildronate action during ischemic stress]M Dambrova, D Daĭia, E Liepin'sh, et al.
Kardiologiia|December 4, 2014
[Carnitine as a marker of atherosclerosis and other risks of cardiovascular diseases]M Dambrova, M Makretskaia, R Vilshkersts, et al.
Molecular Neurobiology|April 30, 2017
The Differentiation of Skin Mesenchymal Stem Cells Towards a Schwann Cell Phenotype: Impact of Sigma-1 Receptor ActivationL Saulite, E Vavers, L Zvejniece, et al.
Archives of Biochemistry and Biophysics|April 25, 2000
N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radicalM Dambrova, L Baumane, A Kiuru, et al.
Biochemical Pharmacology|November 5, 1998
Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. I. Description of an enzymatic activity in spleen membranesS Uhlén, M Dambrova, G Tiger, et al.
Pageof 2